Cipla hits fresh all-time high in a volatile market; rallies 12% in 1 week

Going forward, significant momentum in Cipla will likely continue due to US gains on the back of peptide portfolio unlocking and possible approvals and launches of gRevlimid, gAdvair and gAbraxane

Shares of Cipla hit a fresh all-time high of Rs 1,083.15, up 3.3 per cent on the BSE in Tuesday's intra-day trade, in an otherwise volatile market. As of 11:10 AM, the stock traded 1.6 per cent higher at Rs 1,065. In comparison, the S&P BSE Sensex was down 0.2 per cent at 56,392. In the past one week, the stock has rallied 12 per cent, as against a 5.4-per cent gain in the benchmark index.


The stock of the drug maker was quoting higher for the seventh straight trading day. Moreover, since February 25 (last 12 trading